RecallRadar

FDA Device recall Z-0820-2020

Koios DS Breast <series 1.0>. The device is a software application which assists skilled physicians in analyzing breast ultrasound images

On 2020-01-29 the FDA classified a Class II recall of Koios DS Breast <series 1.0>. The device is a software application which assists skilled physicians in analyzing breast ultrasound images by Koios Medical, citing affected software product versions were found during internal audit to have been marketed for sale without sufficient documentation pertaining to certain required quality procedur….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0820-2020
ClassificationClass II
Statusterminated
Initiated2019-12-31
Published2020-01-29
Last updated2026-09-13 11:55 UTC
CompanyKoios Medical
DistributionMO, NJ, NY

Product

Koios DS Breast <series 1.0>. The device is a software application which assists skilled physicians in analyzing breast ultrasound images.

Reason

Affected software product versions were found during internal audit to have been marketed for sale without sufficient documentation pertaining to certain required quality procedures.

Identifiers

code_info
Models/Versions: 1.2.df61abccd836; 1.2.576fd5569198; 1.3.51a5fadf18dd; 1.3.1.b5c53f1fc08d; 1.3.1.694531bfb9c7; 1.3.1.aa…Models/Versions: 1.2.df61abccd836; 1.2.576fd5569198; 1.3.51a5fadf18dd; 1.3.1.b5c53f1fc08d; 1.3.1.694531bfb9c7; 1.3.1.aaffb0cc2485; 1.3.2.6a67eb8088ed; 1.4.a7e352273dd6; 1.6.1.1*; 1.6.2.1* *Note: versioning scheme was modified to encompass the Build/Commit Number into a fourth digit with the development of version 1.5 (which was never distributed).

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0820-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.